Stanex Drugs And Chemicals Private Limited, a active private limited company, was established on 28 December 2004 in Hyderabad, Telangana, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: U24239TG2004PTC044988. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.75 Cr.
It upholds a compliant status. Employing 46 professional, Its leadership includes Sridevi Kamireddy (Director), Bhagavan Reddy Kamireddy (Managing Director), Nitya Kamireddy (Director). Past directors included Yella Reddy Kamireddy, Ramalinga Reddy Sudini. It holds ₹25.41 Cr open charges and ₹5.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.N.16-140/1, Street No: 3Prashanti Nagar Uppal, Hyderabad, Telangana, 500039.
U24239TG2004PTC044988
044988
28 December 2004
₹1.75 Cr
₹1.75 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Stanex Drugs And Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sridevi Kamireddy | Director | 28 Dec 2004 | Current |
| Bhagavan Reddy Kamireddy | Managing Director | 28 Dec 2004 | Current |
| Nitya Kamireddy | Director | 29 Apr 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jul 2024 | Past |
| Pramod Abcsdd | Director | 29 Apr 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stanex Drugs And Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.74% decrease. The company also saw a substantial improvement in profitability, with a 27.69% increase in profit. The company's net worth Soared by an impressive increase of 17.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Stanex Drugs And Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹254,118,321.00
₹54,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 May 2025 | Others | ₹9.67 M | Open |
| 30 Dec 2024 | Others | ₹7.73 M | Open |
| 28 Mar 2022 | Others | ₹2.58 M | Open |
| 23 Sep 2021 | Others | ₹20.64 Cr | Open |
| 29 Apr 2020 | Others | ₹6.83 M | Open |
Explore comprehensive loan charge details -
Stanex Drugs And Chemicals has a workforce of 46 employees as of Sep 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Stanex Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stanex Drugs And Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.97 Cr with Charge ID 101109412 was registered on 31 May 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 0.77 Cr with Charge ID 101037578 was registered on 30 Dec 2024. was completed.
Stanex Drugs And Chemicals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Stanex Drugs And Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on A charge with Others of Rs. 20.64 Cr registered on 23 Sep 2021 with Charge ID 100488750 was modified on 16 Mar 2024. was documented.
The activity Nitya Kamireddy was appointed as a Director was appointed as a Director on 29 Apr 2023 & has been associated with this company since 2 years 7 months . was completed.
The CIN of Stanex Drugs And Chemicals Private Limited is U24239TG2004PTC044988.
Stanex Drugs And Chemicals Private Limited is headquartered at D.N.16-140/1, Street No: 3Prashanti Nagar Uppal, Hyderabad, Telangana, 500039.
Stanex Drugs And Chemicals Private Limited was incorporated on 28 December 2004.
The current directors of Stanex Drugs And Chemicals Private Limited are
The primary industry of Stanex Drugs And Chemicals Private Limited is Manufacturing.
Stanex Drugs And Chemicals Private Limited is unlisted.
The authorized capital of Stanex Drugs And Chemicals Private Limited is ₹1.75 Cr, and the paid-up capital is ₹1.75 Cr.
The compliance status of Stanex Drugs And Chemicals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX